Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Name: Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
License: Public Domain

Wyeth is now a wholly owned subsidiary of Pfizer

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

bacterial infections, diabetic foot, osteomyelitis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 451487
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.